THE STATE OF THE PROOXIDANT-ANTIOXIDANT SYSTEM IN THE LIVER OF ALLOXAN DIABETIC RATS IN THE CONDITIONS OF MELATONIN INTRODUCTION
DOI:
https://doi.org/10.11603/mcch.2410-681X.2019.v.i2.10304Keywords:
alloxan diabetes mellitus, melatonin, liver, prooxidant-antioxidant systemAbstract
Introduction. An experimental model of alloxan diabetes mellitus is often used to study the pathogenesis of diabetes. In diabetes, oxidative stress is increased, which leads to depletion of the antioxidant system. Melatonin is an antioxidant and activates the body's defenses, protecting it from diseases associated with the activation of free radical processes.
The aim of the study – to determine the effect of melatonin on the prooxidant and antioxidant status in the liver of alloxan diabetic rats.
Research Methods. Experiments were conducted on white outbred sexually mature male rats. The content of oxidatively modified proteins, TBA-active products, the activity of catalase and superoxide dismutase (SOD) was determined in the liver.
Results and Discussion. The results of our research showed that under the conditions of alloxan diabetes mellitus is activation of free radical oxidation of biomolecules, as evidenced increase the content of TBA-products and oxidatively modified proteins on the 7th and 14th days of the experiment in the liver of alloxane diabetic rats. At the same time, decrease of activity of catalase and superoxide dismutase is observed in the liver of rats in diabetic group. The positive effect of melatonin is shown in the decrease the content of TBA-active products and oxidatively modified proteins in the liver compared to group of alloxan diabetic animals. In addition, the use of melatonin contributed to the normalization the activity of antioxidant enzymes in rat liver with alloxan diabetes: increase the activity of catalase and superoxide dismutase compared to diabetic group.
Conclusion. In the conditions of exogenous melatonin introduction to rats with alloxan diabetes in a dose of 10 mg/kg daily for 7 and 14 days cause a pronounced antioxidant effect, reducing free radical oxidation and normalizing the activity of enzymes of antioxidant defense in the liver of alloxan diabetic rats.
References
Rojas, J., Bermudez, V., Palmar, J. Martínez, M.S., Olivar, L.C., Nava, M., Tomey, D., Rojas M., Salazar, J., Garicano, C., & Velasco, M. (2018). Pancreatic beta cell death: novel potential mechanisms in diabetes therapy. Journal of Diabetes Research. Article ID 9601801, 19. doi.org/10.1155/2018/9601801. DOI: https://doi.org/10.1155/2018/9601801
Zhang, Y., Yuan, D., Yao, W., Zhu, Q., Liu, Y., Huang, F., … Hei, Z. (2016). Hyperglycemia aggravates hepatic ischemia reperfusion injury by inducing chronic oxidative stress and inflammation. Oxidative Medicine and Cellular Longevity. 3919627. doi:10.1155/2016/ 3919627.
Sezen, S.C., Işık, B., Bilge, M., Arslan, M., Çomu, F.M., Öztürk, L., Kesimci, E., Kavutçu, M. (2016). Effect of dexmedetomidine on ischemia-reperfusion injury of liver and kidney tissues in experimental diabetes and hepatic ischemia-reperfusion injury induced rats. Anaesth Pain & Intensive Care, 20 (2), 143-149.
Wang, C.K., Ahmed, M.M., Jiang, Q., Lu, N., Tan, C., Gao, Y., … Han, F. (2017). Melatonin ameliorates hypoglycemic stress-induced brain endothelial tight junction injury by inhibiting protein nitration of TP53-induced glycolysis and apoptosis regulator. J. Pineal Res., 63 (4), e12440. doi:10.1111/jpi.12440. DOI: https://doi.org/10.1111/jpi.12440
Akinola, O., Gabriel, M., & Suleiman, A. (2012). Treatment of alloxan-induced diabetic rats with metformin or glitazones is associated with amelioration of hyperglycaemia and neuroprotection. The Open Diabetes Journal, 5, 8-12. DOI: https://doi.org/10.2174/1876524601205010008
Kamyshnikov, V.S. (2002). Spravochnik po kliniko-biokhimicheskoy laboratornoy diagnostike (2nd ed.) [Handbook of clinical and biochemical laboratory diagnostics]. Minsk [in Russian].
Meshchyshen, I.F. (1998). Metod vyznachennia okysno modyfikovanykh bilkiv plazmy (syrovatky) krovi [Method of determination of oxidative modifiers of plasma (serum) of blood]. Bukovynskyi medychnyi visnyk – Bukovyna Medical Bulletin, 2, (1), 156–158 [in Ukrainian].
Koroliuk, K.A., Ivanova, L.I., & Maiorova, I.G. (1988). Metod opredeleniya aktivnosti katalazy [Method of determination of catalase activity]. Laboratornoye delo – Laboratory Work, 1, 16-19 [in Russian].
Dubynina, E.E., Salnykova, L.A., & Efymova, L.F. (1983). Aktivnost i izofermentnyy spektr superoksyddismutazy eritrotsytov y plazme krovi cheloveka [Activity and isoenzyme spectrum of erythrocyte superoxide dismutase and human blood plasma]. Laboratornoye delo – Laboratory Work, 10, 30-33 [in Russian].
Mohamed, J., Nazratun Nafizah, A. H., Zariyantey, A.H., & Budin, S.B. (2016). Mechanisms of diabetes-induced liver damage: The role of oxidative stress and inflammation. Sultan Qaboos University Medical Journal, 16 (2), e132-e141. doi:10.18295/squmj.2016.16. 02.002.
Espino, J., Pariente, J.A., & Rodríguez, A.B. (2011). Role of melatonin on diabetes-related metabolic disorders. World J. Diabetes, 2 (6), 82-91. DOI: https://doi.org/10.4239/wjd.v2.i6.82
Szewczyk-Golec, K., Rajewski, P., Gackowski, M., Mila-Kierzenkowska, C., Wesołowski, R., Sutkowy, P., … Woźniak, A. (2017). Melatonin supplementation lowers oxidative stress and regulates adipokines in obese patients on a calorie-restricted diet. Oxidative Medicine and Cellular Longevity, 2017, 8494107. doi:10.1155/2017/ 8494107.
Luhinich, N.M., Herush, I.V., Yaremii, I.M., & Davydova, N.V., (2018). Vplyv 14 dobovoho vvedennia melatoninu na metabolizm hlutationu v pechintsi shchuriv pry aloksanovomu tsukrovomu diabeti [Influence of 14 daily administration of melatonin on glutathione metabolism in rat liver with aloxane diabetes mellitus]. Naukovi zapysky Ternopilskoho natsionalnoho pedahohichnoho universytetu imeni Volodymyra Hnatiuka. Seriia: Biolohiia – Scientifical Notes of Ternopil National Pedagogical University named after Volodymyr Hnatiuk. Series "Biology", 3-4 (74), 1-75 [in Ukrainian].
Bonnefond, A., & Froguel, P. (2017). The case for too little melatonin signalling in increased diabetes risk. Diabetologia, 60, 823-825. DOI: https://doi.org/10.1007/s00125-017-4255-x
